Skip to main content

A New Pathway in Psoriatic Arthritis: Dr. Eric Ruderman

Nov 09, 2020 6:36 am

Dr. Ruderman discusses a new pathway - the use of deucravacitinib - for the treatment of psoriatic arthritis (abstracts L03) at the ACR 2020 annual meeting.

Add new comment

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×